These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7870746)

  • 21. Suppression of catatonia-like signs by lorazepam in nonconvulsive status epilepticus without seizure termination.
    Swartz CM; Bottum KM; Salazar Jr LS
    Am J Geriatr Psychiatry; 2002; 10(3):348-50. PubMed ID: 11994224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurring episodes of Bell's mania after cerebrovascular accident.
    Bobo WV; Murphy MJ; Heckers SH
    Psychosomatics; 2009; 50(3):285-8. PubMed ID: 19567770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lorazepam and diazepam for relieving catatonic features precipitated by initial hemodialysis in a uremic patient: a case report.
    Tsai MC; Huang TL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):423-4. PubMed ID: 20026370
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of catatonia with low-dose lorazepam.
    Greenfeld D; Conrad C; Kincare P; Bowers MB
    Am J Psychiatry; 1987 Sep; 144(9):1224-5. PubMed ID: 3631326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia.
    Northoff G; Pfennig A; Krug M; Danos P; Leschinger A; Schwarz A; Bogerts B
    Schizophr Res; 2000 Sep; 44(3):193-211. PubMed ID: 10962222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopathology of catatonic speech disorders and the dilemma of catatonia: a selective review.
    Ungvari GS; White E; Pang AH
    Aust N Z J Psychiatry; 1995 Dec; 29(4):653-60. PubMed ID: 8825829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lorazepam and diazepam rapidly relieve catatonic features in major depression.
    Hung YY; Huang TL
    Clin Neuropharmacol; 2006; 29(3):144-7. PubMed ID: 16772813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The syndrome of lethal catatonia.
    Tang CP; Leung CM; Ungvari GS; Leung WK
    Singapore Med J; 1995 Aug; 36(4):400-2. PubMed ID: 8919156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catatonia in DSM 5: controversies regarding its psychopathology, clinical presentation and treatment response.
    Ungvari GS
    Neuropsychopharmacol Hung; 2014 Dec; 16(4):189-94. PubMed ID: 25577482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis.
    Lin CC; Huang TL
    Compr Psychiatry; 2013 Nov; 54(8):1210-4. PubMed ID: 23856388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catatonia in systemic lupus erythematosus: a case report and review of literature.
    Grover S; Parakh P; Sharma A; Rao P; Modi M; Kumar A
    Lupus; 2013 May; 22(6):634-8. PubMed ID: 23690443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapses and recurrences of catatonia: 30-case analysis and literature review.
    Lin CC; Hung YY; Tsai MC; Huang TL
    Compr Psychiatry; 2016 Apr; 66():157-65. PubMed ID: 26995249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catatonia: short-term response to lorazepam and dopaminergic metabolism.
    Northoff G; Wenke J; Demisch L; Eckert J; Gille B; Pflug B
    Psychopharmacology (Berl); 1995 Nov; 122(2):182-6. PubMed ID: 8848534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Catatonia].
    Bruijn DJ; Blom JD
    Ned Tijdschr Geneeskd; 2010; 154():A2284. PubMed ID: 20977815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lorazepam and diazepam for relieving catatonic features in multiple sclerosis.
    Hung YY; Huang TL
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1537-8. PubMed ID: 17640789
    [No Abstract]   [Full Text] [Related]  

  • 36. A16-year-old girl with excited catatonia treated with low-dose oral Lorazepam.
    Pruett JR; Rizvi ST
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):1005-10. PubMed ID: 16379521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I; Colombo G; Furlanut M; Benetello P
    Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.
    Ungvari GS; Chiu HF; Chow LY; Lau BS; Tang WK
    Psychopharmacology (Berl); 1999 Mar; 142(4):393-8. PubMed ID: 10229064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical predictors of response to treatment in catatonia.
    Narayanaswamy JC; Tibrewal P; Zutshi A; Srinivasaraju R; Math SB
    Gen Hosp Psychiatry; 2012; 34(3):312-6. PubMed ID: 22387048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.
    Hung YY; Yang PS; Huang TL
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):256-8. PubMed ID: 16594953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.